Table 4 Clinical outcomes by target refractive power.
From: Multicenter clinical outcomes of hole implantable collamer lens implantation in middle-aged patients
Pre-UDVA | Pre-CDVA | Pre-SE (D) | Target ref (D) | Post-UDVA | Safety index | Efficacy index | Post-SE (D) | Predictability (± 1.0D) | |
|---|---|---|---|---|---|---|---|---|---|
Bilateral Emmetropia (N = 54eyes) | 1.38 ± 0.27 | − 0.15 ± 0.11 | − 9.14 ± 3.70 | − 0.10 ± 0.19 | − 0.07 ± 0.18 | 1.11 ± 0.22 | 0.88 ± 0.26 | − 0.40 ± 0.57 | 93% |
Monovision (N = 26eyes DE:13/NDE:13) | DE 1.37 ± 0.22 NDE: 1.44 ± 0.24 | DE: − 0.16 ± 0.06 NDE: − 0.16 ± 0.07 | DE: − 8.05 ± 3.65 NDE: − 8.55 ± 3.84 | DE: − 0.31 ± 0.24 NDE: − 1.14 ± 0.41 | DE: − 0.03 ± 0.21 NDE: 0.21 ± 0.32 | DE: 1.09 ± 0.17 NDE: 1.06 ± 0.18 | DE: 0.80 ± 0.24 NDE: 0.52 ± 0.30 | DE: − 0.37 ± 0.42 NDE: − 1.10 ± 0.73 | DE: 100% NDE: 100% |
Bilateral Intentional-Undercorrection (N = 26eyes) | 1.46 ± 0.20 | − 0.16 ± 0.09 | − 10.17 ± 2.94 | − 0.78 ± 0.33 | 0.08 ± 0.22 | 1.02 ± 0.20 | 0.65 ± 0.29 | − 0.80 ± 0.63 | 92% |
